GH Research PLC (GHRS)
10.51
+0.01
(+0.10%)
USD |
NASDAQ |
Apr 26, 16:00
10.51
0.00 (0.00%)
After-Hours: 16:03
GH Research Shareholders Equity (Quarterly): 218.97M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 218.97M |
| September 30, 2023 | 225.77M |
| June 30, 2023 | 232.98M |
| March 31, 2023 | 241.83M |
| December 31, 2022 | 249.82M |
| September 30, 2022 | 256.74M |
| June 30, 2022 | 263.22M |
| Date | Value |
|---|---|
| March 31, 2022 | 269.48M |
| December 31, 2021 | 277.18M |
| September 30, 2021 | 283.60M |
| June 30, 2021 | 288.23M |
| March 31, 2021 | 4.315M |
| December 31, 2020 | 5.666M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.315M
Minimum
Mar 2021
288.23M
Maximum
Jun 2021
216.75M
Average
249.82M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp PLC | 552.10M |
| Jazz Pharmaceuticals PLC | 3.737B |
| Prothena Corp PLC | 561.36M |
| Iterum Therapeutics PLC | -6.403M |
| Mural Oncology PLC | 263.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 226.30M |
| Total Liabilities (Quarterly) | 7.332M |